During the COVID-19 global pandemic, cancer patients and physicians must carefully weigh the potential benefit of routine cancer care versus the high morbidity and mortality of COVID-19, especially in patients of older age, patients with comorbidities, and those with cancer.(1) Staff and resources may also be redistributed to care for COVID-19 patients, and thus judicious use of resources is critical during this time.